Systemic CD4 Immunity and PD-L1/PD-1 Blockade Immunotherapy.

Int J Mol Sci · 2022 · PMC9655397 · PMID 36362027

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

In agreement with this study, we found a highly significant association between the baseline percentage of HLA-DR+ CD14+ monocytic cells and objective responses in NSCLC patients under PD-L1/PD-1 blockade by high-dimensional flow cytometry in peripheral blood [ 45 ].

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.